Automating the Point of Care: The Getein 1600 and the Push for High-Throughput Decentralized Diagnostics

Getein 1600 Immunofluorescence Quantitative Analyzer | Fully Automated POCT Analyzer for High-Throughput Clinical Diagnostics

The Getein 1600 is a fully automated immunofluorescence analyzer that operates at the intersection of speed and scale. It processes up to 150 tests per hour, handling 48 samples in a single run, with results emerging in three to fifteen minutes. That positions it not as a simple POCT device, but as a serious piece of lab infrastructure that happens to fit outside the main lab.

What makes it operationally distinct is the automation of the entire workflow—sampling, dilution, analysis, reporting. Manual error drops, technician time is freed, and the machine accepts whole blood, serum, plasma, or urine with as little as 10 microliters. That flexibility matters in emergency departments and ICUs where sample type and volume are unpredictable.

Its integration with LIS and HIS systems is not a footnote. The Getein 1600 is built to feed directly into hospital data infrastructure, meaning results become part of the patient record without manual transcription. In high-volume settings, that reduces both delay and error risk.

The machine’s physical footprint—639 by 562 by 728 millimeters—and its weight of 45 kilograms indicate it was designed for a fixed station rather than handheld mobility. This is a unit intended for dedicated use, not ad-hoc deployment.

For procurement, the 150-test-per-hour throughput makes it a direct cost comparison against small central lab analyzers, but with the operational advantage of location. Hospitals can place it where the demand lives, reducing sample transport time and the associated logistical burden.

China’s role here is significant. Getein is a domestic manufacturer producing a device that competes on specification with multinational offerings, but likely at a price point that suits the procurement budgets of large Chinese hospital groups and expanding regional health networks. The Getein 1600 reflects a maturing industrial capability: not just making diagnostic tools, but making them fit for system-wide deployment.

The real shift is not the technology. It is that the line between central lab and point-of-care has blurred to the point where the same machine can serve both roles effectively.

Why it matters:
For hospital administrators, the Getein 1600 offers a single-device solution that reduces sample logistics and central lab bottlenecks. For suppliers, it signals that China’s POCT market is moving toward automated, high-throughput systems that challenge traditional lab instrument procurement.

View Product →